Affordable Access

Access to the full text

Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants

Authors
  • Venkataraman, Lalitha1
  • He, Ping2
  • Khan, Galam3
  • Harris, Brent T.3, 3
  • Sierks, Michael R.2
  • 1 Arizona State University, Tempe, AZ, USA , Tempe (United States)
  • 2 Arizona State University, ECG301-501 Tyler Mall, Tempe, AZ, 85281-6106, USA , Tempe (United States)
  • 3 Georgetown University Medical Center, Washington, DC, USA , Washington (United States)
Type
Published Article
Journal
BMC Neuroscience
Publisher
Springer (Biomed Central Ltd.)
Publication Date
Sep 04, 2020
Volume
21
Issue
1
Identifiers
DOI: 10.1186/s12868-020-00586-0
Source
Springer Nature
Keywords
License
Green

Abstract

BackgroundFrontotemporal dementia (FTD) is the second leading cause of early onset dementia following Alzheimer’s disease. It involves atrophy of the frontal and temporal regions of the brain affecting language, memory, and behavior. Transactive response DNA-binding protein 43 (TDP-43) pathology is found in most FTD and ALS cases. It plays a role in transcription, translation and serves as a shuttle between the nucleus and cytoplasm. Prior to its aggregation, TDP-43 exists as polyubiquitinated, hyperphosphorylated C-terminal fragments that correlate well with FTD disease progression. Because of the importance of TDP-43 in these diseases, reagents that can selectively recognize specific toxic TDP variants associated with onset and progression of FTD can be effective diagnostic and therapeutic tools.ResultsWe utilized a novel atomic force microscopy (AFM) based biopanning protocol to isolate single chain variable fragments (scFvs) from a phage display library that selectively bind TDP variants present in human FTD but not cognitively normal age matched brain tissue. We then used the scFvs (FTD-TDP1 through 5) to probe post-mortem brain tissue and sera samples for the presence of FTD related TDP variants. The scFvs readily selected the FTD tissue and sera samples over age matched controls. The scFvs were used in immunohistochemical analysis of FTD and control brain slices where the reagents showed strong staining with TDP in FTD brain tissue slice. FTD-TDP1, FTD-TDP2, FTD-TDP4 and FTD-TDP5 all protected neuronal cells against FTD TDP induced toxicity suggesting potential therapeutic value.ConclusionsThese results show existence of different disease specific TDP variants in FTD individuals. We have identified a panel of scFvs capable of recognizing these disease specific TDP variants in postmortem FTD tissue and sera samples over age matched controls and can thus serve as a biomarker tool.

Report this publication

Statistics

Seen <100 times